Careers  |  Sign In  |  Register  |   Twitter

Risk of Infections with Etanercept

FDA announces boxed warning

The FDA has announced a boxed warning has been added to the label for etanercept (Enbrel), for rheumatoid arthritis, to strengthen awareness of the risk of infections and particularly TB.

References and Resources

Sponsored by The Doctor’s Channel